HUB’s Bot: Rising Specialty Drugs, Inflation Challenge Employer Benefits

Kirsten Bot, national director, actuarial services and financial consulting, HUB International, discusses emerging trends in benefits and how proactive strategies can curb medical and pharmaceutical inflation.